Close Menu

microarrays

Move over microarray listservs, there s a new kid on the Internet block. The USENET newsgroup bionet.molbio.genearrays has been opened up for an unmonitored discussion of all topics related to microarray and gene array technology.

Marking the 25th sale of a Microfluidics Tool Kit system, Micralyne of Edmonton, Alberta, said it sold a system to the University of California Berkeley.

To Better bridge the atomistic microcosms of microarray research, David Allison, a professor of biostatistics at the University of Alabama at Birmingham School of Public Health has received a $409,000 grant from the National Science Foundation.

Sharing a first name and a vision, Whitehead Fellow David Sabatini and former McKinsey & Company consultant David Chao are starting an as-yet unnamed company to commercialize cell-based gene expression microarrays.

The scientists at Hayward, Calif.-based Biolog have turned the concept of microarraying inside out: Instead of measuring thousands of different genes from a cell, Biolog s Phenotype Microarrays, which company scientists outline in a June 25 paper published in Genome Research, measure the effect of one gene on thousands of different cell conditions.

Compugen and Sigma-Aldrich subsidiary Sigma-Genosys have inked a deal to jointly design, manufacture, and market oligonucleotide libraries.

With 28 years of experience in the medical lab business, Nanogen s new CEO Randy White is steering the company firmly toward diagnostic applications of its biochip platform.

PATENT WATCH: Jun 22, 2001

Premium

PamGene of Den Bosch, Netherlands said it has received a US patent, number 6,225,131, describing PamGene’s flow-through microarray testing technology. In this technology, samples flow through microarrays made of a porous aluminum oxide.

Ventana Medical Systems of Tucson, Ariz., has introduced two new chemistry kits for DNA microarray experiments on its Discovery automated slide-staining instrument.

Nanogen of San Diego recently announced that Michael Heller, the company’s chief technical officer and co-founder, is leaving his position to take a job as a professor at an unnamed university.

Pages

The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine. 

The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.

The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.

In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.